MIR1233-1
associated omics dataQ-omics provides the consensus-scored MIR1233-1 profile across patient tissues and cancer cell-line models. MIR1233-1 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in GBM.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR1233-1 — synthetic lethality, tumor antigen, and pembrolizumab response.
View premium →Survival associations
This table summarizes MIR1233-1 survival associations across molecular data types. MIR1233-1 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR1233-1 RNA expression–survival associations across cancer types. High MIR1233-1 expression shows favorable associations in GBM. The GBM Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .036). Together, the overview and detailed table identify GBM as the clearest survival context for MIR1233-1 RNA expression.
